Elsewhere on HealthThreads: Thyroid cancer | Overactive bladder | Lymphoma | Stomach cancer |
July 16, 2009 – A new study by UT Southwestern Medical Center researchers sheds light on the challenges involved in identifying which high-risk population would benefit most from bladder-cancer screening.Large-scale screening of people at high risk for developing invasive bladder...
SYS-CON Media (press release) There is a high unmet need in the treatment of recurrent CIS bladder tumors because, generally, they do not respond well to chemotherapy. BCG immunotherapy shows the best efficacy against recurrent CIS bladder tumors, but patients often show poor ...
Thu, Mar 19 | from drugdiscovery.pharmaceutical-business-review.com